Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

A. E. Rab, Minke; Bos, Jennifer; A. van Oirschot, Brigitte; H.A.S., Stéphanie van Straaten; A. Kosinski, Penelope; Chubukov, Victor; Kim, Hyeryun; Mangus, Heidi; E. G. Schutgens, Roger; Pasterkamp, Gerard; Dang, Lenny; Kung, Charles; J. van Beers, Eduard; van Wijk, Richard

doi:10.1182/blood.2020008635

Minke A. E. Rab, Jennifer Bos, Brigitte A. van Oirschot, H.A.S. (Stéphanie) van Straaten, Penelope A. Kosinski, Victor Chubukov, Hyeryun Kim, Heidi Mangus, Roger E. G. Schutgens, Gerard Pasterkamp, et al. Lenny Dang, Richard van Wijk

2021-05-27

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Blood , Volume 137 - Issue 21 p. 2997- 3001

Additional Metadata
Persistent URL	doi.org/10.1182/blood.2020008635, hdl.handle.net/1765/136287
Journal	Blood
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Minke A. E. Rab, Jennifer Bos, Brigitte A. van Oirschot, H.A.S. (Stéphanie) van Straaten, Penelope A. Kosinski, Victor Chubukov, … Richard van Wijk. (2021). Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy. Blood, 137(21), 2997–3001. doi:10.1182/blood.2020008635

View at Publisher

Free Full Text ( Final Version )

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Publication

Publication

About

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Publication

Publication

Workflow

Workflow

Add Content